PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2806756-1	1989	The effects of the selective muscarinic M1-receptor antagonist pirenzepine and the nonselective muscarinic antagonist atropine on bombesin- and peptone-stimulated release of pancreatic polypeptide (PP) were studied in healthy subjects.	Atropine	118-126	gastrin releasing peptide	Homo sapiens	130-138	
2683738-4	1989	Atropine (500 micrograms, im) inhibited significantly (p less than 0.01) the gallbladder contraction (maximum contractile rate, 78.7 +/- 6.4%) in response to bombesin without any change of plasma CCK secretion, whereas proglumide (800 mg/day for 3 days, per os) decreased slightly but not significantly the gallbladder contraction, and had no effect on plasma CCK secretion.	Atropine	0-8	gastrin releasing peptide	Homo sapiens	158-166	
2683738-6	1989	These findings suggest that atropine inhibits bombesin-induced gallbladder contraction, not via suppression of CCK release, but probably by inhibiting cholinergic mechanisms, whereas somatostatin inhibits gallbladder contraction, at least in part, by the suppression of bombesin-stimulated CCK secretion.	Atropine	28-36	gastrin releasing peptide	Homo sapiens	46-54	
2888697-0	1987	Effect of atropine and somatostatin on bombesin-stimulated plasma immunoreactive trypsin release in man.	Atropine	10-18	gastrin releasing peptide	Homo sapiens	39-47	
2834614-3	1988	The atropine-sensitive contraction and nonadrenergic noncholinergic relaxation in responses to FES which were tetrodotoxin-sensitive significantly increased in amplitude after bombesin.	Atropine	4-12	gastrin releasing peptide	Homo sapiens	176-184	
2885900-6	1987	There were great differences between the effects of atropine and somatostatin on the hormonal responses to bombesin.	Atropine	52-60	gastrin releasing peptide	Homo sapiens	107-115	
2885900-7	1987	Atropine slightly increased the response of gastrin by 19% and that of cholecystokinin by 15%, but strongly inhibited the bombesin-stimulated pancreatic polypeptide secretion by 97%.	Atropine	0-8	gastrin releasing peptide	Homo sapiens	122-130	
3691621-1	1987	We have studied the effects of the selective muscarinic M1-receptor antagonist pirenzepine and the non-selective muscarinic antagonist atropine on bombesin- and peptone-stimulated gastrin release in healthy subjects.	Atropine	135-143	gastrin releasing peptide	Homo sapiens	147-155	
2888697-1	1987	This study was undertaken to determine the effect of atropine and somatostatin, two inhibitors of intraduodenal pancreatic enzyme secretion, on bombesin-stimulated release of plasma immunoreactive trypsin in 6 healthy volunteers.	Atropine	53-61	gastrin releasing peptide	Homo sapiens	144-152	
3976887-3	1985	Atropine at 1 mumol/l diminished the protein secretion in response to infusion of GRP at a dose of 1 nmol/l to 45% of control.	Atropine	0-8	gastrin releasing peptide	Homo sapiens	82-85	
6647889-0	1983	The effect of atropine on bombesin and gastrin releasing peptide stimulated gastrin, pancreatic polypeptide and neurotensin release in man.	Atropine	14-22	gastrin releasing peptide	Homo sapiens	26-34	
6647889-8	1983	Atropine blocked the release of PP during GRP and neurotensin infusion.	Atropine	0-8	gastrin releasing peptide	Homo sapiens	42-45	
6647889-9	1983	Atropine had no effect on neurotensin or PP release during bombesin infusion, but did block the rise in plasma PP following bombesin infusion.	Atropine	0-8	gastrin releasing peptide	Homo sapiens	124-132	
7433514-0	1980	Antagonism of the gut-contracting effects of bombesin and neurotensin by opioid peptides, morphine, atropine or tetrodotoxin.	Atropine	100-108	gastrin releasing peptide	Homo sapiens	45-53	
7433514-1	1980	Morphine, met-enkephalin, beta-endorphin, tetrodotoxin (TTX), and atropine antagonized the gut-contracting effects of the peptides neurotensin and bombesin.	Atropine	66-74	gastrin releasing peptide	Homo sapiens	147-155